Nuveen Asset Management, LLC Nymox Pharmaceutical Corp Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.48 $224,644 - $381,587	-153,866 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.22 - $3.39 $7,698 - $11,756	-3,468 Reduced 2.2%	153,866 $341,000
Q4 2020 Feb 16, 2021	BUY	$1.84 - $2.83 $3,383 - $5,204	1,839 Added 1.18%	157,334 $390,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.66 $41 - $65	-18 Reduced 0.01%	155,495 $382,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $4.6 $326,577 - $715,359	155,513 New	155,513 $552,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.